female scientist inspecting beaker

Research & Progress

ASCO advances clinical research through scientific meetings, educational programs, and peer-reviewed journals designed to help translate research results into quality care.

  • TAPUR Study Adds More Sites, Participants and Collaborators

    ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study continues to expand and now has more than 300 participants enrolled on study drug, more than 100 sites, new partnerships, and a revised protocol to lower the age of eligibility.

    Learn More
  • CancerLinQ, FDA Partner to Study Real-World Use of Emerging Treatments

    CancerLinQ LLC has announced a long-term partnership with the Food and Drug Administration (FDA) that will harness cancer patient information and big data analytics to examine the real-world use of emerging and newly approved cancer therapies.

    Learn More
  • Survey Open: Be Counted in the 2017 ASCO Practice Census

    Participate in the only annual survey of the entire U.S. oncology practice community, which aims to capture and describe the changes in cancer care and oncology practice over time. Insights generated from the census are used to inform initiatives across ASCO.

    Take Survey

Random Quote

"At ASCO, there's a place for everyone from every corner of oncology and the world."
Allen S. Lichter, MD, FASCO
ASCO CEO 2006-2016